̽»¨Ö±²¥

Apollo Therapeutics, a biopharmaceutical company originally set up by three UK universities (Cambridge, Imperial College London and  ̽»¨Ö±²¥ College London) and three pharmaceutical companies (AstraZeneca, GSK and Johnson & Johnson Innovation), has secured $226.5 million venture capital financing.

̽»¨Ö±²¥ ̽»¨Ö±²¥ of Cambridge has formed a new agreement with AstraZeneca for the global biopharmaceuticals company to fund 55 additional PhD studentships over the next five years, starting in October 2022. Over the last 20 years, AstraZeneca has funded more than 100 PhD students from the ̽»¨Ö±²¥ as part of a longstanding partnership between the two institutions.

Researchers in the UK and China have developed an artificial intelligence (AI) model that can diagnose COVID-19 as well as a panel of professional radiologists, while preserving the privacy of patient data.

̽»¨Ö±²¥Cambridge COVID-19 Testing Centre, set up in April in response to the urgent need to boost the UK’s testing capabilities, has processed two million tests.